Calendar Recce Pharmaceuticals Ltd

Equities

Delayed Australian S.E. Other stock markets 01:51:48 02/05/2024 BST			5-day change	1st Jan Change
0.64 ^AUD	-3.03%		-1.54%	+19.63%

04-30	Recce Pharmaceuticals Ltd. Announces Safety Committee Approves High Dose of 4,000mg in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis	CI
04-17	Recce Pharmaceuticals Ltd. Completes 5,000 RECCE 327 Doses Week Under Good Manufacturing Practice	CI

03.gYZs1Jnk8e9Ei-AV52DNRak1R8PAN5ZwU_h3VXjTjLI.8dxdpuyjgdgK7JghrD-ic5xAL_XwXtMbZs9aIi2hwdTY4Ryn3pCIjg7xlw~a49e11f664d35e2208ec60eddb1d7b1b

29/08/2024	Q4 2024 Earnings Release (Projected)
25/02/2025	Q2 2025 Earnings Release (Projected)
28/08/2025	Q4 2025 Earnings Release (Projected)
03/03/2026	Q2 2026 Earnings Release (Projected)

28/03/2024 23:00	American Society for Clinical Pharmacology & Therapeutics Meeting
28/02/2024 09:21	Q2 2024 Earnings Release
30/01/2024 01:19	December 2023 Sales and Revenue Release - Activities Report
07/11/2023 22:00	Annual General Meeting
20/10/2023 00:28	September 2023 Sales and Revenue Release - Activities Report
31/08/2023 06:34	Q4 2023 Earnings Release
16/08/2023 15:00	Military Health System Research Symposium - Abstract No : MHSRS-23-10081
31/07/2023 09:15	June 2023 Sales and Revenue Release - Activities Report
28/04/2023 05:04	March 2023 Sales and Revenue Release - Activities Report
23/03/2023	Wholesale Investor Emergence Conference
27/02/2023 07:04	Q2 2023 Earnings Release
23/02/2023	Spark Plus Biotech Day
14/02/2023	Wholesale Investor Emergence Conference
29/01/2023	December 2022 Sales and Revenue Release - Activities Report
14/11/2022 03:00	Annual General Meeting
03/11/2022 03:45	Spark Plus Biotech & Medical Device Webinar
28/10/2022 01:48	September 2022 Sales and Revenue Release - Activities Report
30/08/2022	FY 2022 Earnings Release
31/07/2022	June 2022 Sales and Revenue Release - Activities Report
28/07/2022 02:00	Spark Australian Equities Day

Fiscal Period	June	2022	2023	2024
Net sales Million AUD	Released Forecast Spread	0,00	4,31 6,22 -30.68%	5,24
EBITDA Million AUD	Released Forecast Spread	0,00	-12,8 -12,3 -3.88%	-14,8
EBIT Million AUD	Released Forecast Spread	0,00	-12,7 -12,2 -4.23%	-15,0
Earnings before Tax (EBT) Million AUD	Released Forecast Spread	0,00	-13,1 -12,4 -5.1%	-15,3
Net income Million AUD	Released Forecast Spread	-11,0	-13,1 -12,4 -5.1%	-15,3
EPS AUD	Released Forecast Spread	-0,06	-0,08 -0,07 -7.43%	-0,08
Announcement Date		31/08/22	31/08/23	-

Today 06:30	NOVO NORDISK A/S: Q1 2024 Earnings Release
Today 12:30	ORGANON & CO.: Q1 2024 Earnings Release
02/05/2024	SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected)
02/05/2024	AARTI DRUGS LIMITED: Q4 2024 Earnings Release
02/05/2024	ALK-ABELLÓ A/S: Q1 2024 Earnings Release
02/05/2024	DEVA HOLDING: Q1 2024 Earnings Release (Projected)
03/05/2024 11:00	AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
05/05/2024	GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI: Q1 2024 Earnings Release (Projected)
05/05/2024	PLIANT THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
05/05/2024	AVADEL PHARMACEUTICALS PLC: Q1 2024 Earnings Release (Projected)

Today	BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release
Today	AMGEN INC.: Q1 2024 Earnings Release
01/05/2024 21:05	CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release
01/05/2024 21:05	JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release
01/05/2024 11:45	PFIZER, INC.: Q1 2024 Earnings Release
01/05/2024 08:00	HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement
01/05/2024 07:00	GSK PLC: Q1 2024 Earnings Release
30/04/2024	INNOVIVA, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024	PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024	EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)